SEL-148,742

N/A

Report date: 2022/12/16 17:04:25
NME

Base Information

Drug NameSEL-148,742
Drug Alias NameSEL-148742
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgranulin modulators
TargetsProgranulin
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSharp Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A